Quest Diagnostics's most recent trend suggests a bullish bias. One trading opportunity on Quest Diagnostics is a Bull Put Spread using a strike $60.00 short put and a strike $50.00 long put offers a potential 3.63% return on risk over the next 40 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $60.00 by expiration. The full premium credit of $0.35 would be kept by the premium seller. The risk of $9.65 would be incurred if the stock dropped below the $50.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Quest Diagnostics is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Quest Diagnostics is bullish.
The RSI indicator is above 80 which suggests that the stock is in overbought territory.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Quest Diagnostics
CollabRx Teams With Quest Diagnostics in Clinical Genetic Sequencing
Mon, 11 Nov 2013 17:40:18 GMT
noodls – San Francisco, Calif., November 11, 2013 – CollabRx, Inc. (NASDAQ:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, today announced a multi-year, non-exclusive …
CollabRx Teams With Quest Diagnostics in Clinical Genetic Sequencing
Mon, 11 Nov 2013 12:01:00 GMT
GlobeNewswire – SAN FRANCISCO — CollabRx, Inc. , a data analytics company focused on informing clinical decision making in molecular medicine, today announced a multi-year, non-exclusive agreement with Quest Diagnostics …
Quest Diagnostics to Speak at the Credit Suisse 2013 Annual Healthcare Conference
Mon, 11 Nov 2013 03:25:57 GMT
noodls – MADISON, N.J., Nov. 8, 2013 /PRNewswire/ — Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Credit …
Quest Diagnostics to Speak at the Credit Suisse 2013 Annual Healthcare Conference
Fri, 08 Nov 2013 22:25:00 GMT
PR Newswire – MADISON, N.J., Nov. 8, 2013 /PRNewswire/ — Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Credit …
Quest Diagnostics Inc. (DGX) is Overbought, What's Next?
Fri, 08 Nov 2013 11:04:32 GMT
Related Posts
Also on Market Tamer…
Follow Us on Facebook